Govt Job: For M.Pharm, M.Sc under SERB-CRG funded project

Established in 1955 by the visionary industrialist Mr. BM Birla, BIT Mesra was founded with a clear vision to offer its young minds a space, where their imagination could take wings and their ideas fruition.

For over 6 decades now, the institute has nurtured minds with a rich heritage of academic excellence, developing learning frameworks that have been well ahead of times.

Post : Junior Research Fellow (JRF)

Applications are invited for the post of Junior Research Fellow in following project funded under SERB-CRG (2022-2025)

Project title : Development of Novel Antileukemics Through the Structural and Functional Studies of Engineered and Chimeric Plant-Type Asparaginases File No.: CRG//2021/006543

Name of PI& Co-PI : Dr. K K Pradhan, Dr. V K Nigam & Dr. H R Singh

Eligibility : M.Tech./ M.S/ M.Pharm./ M.Sc. in Bioengineering / Biotechnology / Pharm. Biotechnology. NET / GATE / GPAT or other national level examination qualifiers will be preferred.

Desirable skills : Design of Protein expression & purification, Local engineering (circular permutation, linker modification, motifs exchange, randomization),QbD, chimera-genesis and Exposure in SDS-PAGE as well as XRD techniques.

Duration : Initially for a period of 01 year & may be extended for a additional 02 year upon satisfactory performance

Felloship Rs/-pm : 31,000/- + HRA as applicable (First 2 Years) 35,000/- + HRA as applicable (Third Year)

Date and time of Interview :26th April 2022 & at 9.15 AM

Venue : Department of Pharmaceutical Sciences& Technology, BIT-Mesra

• Interested candidates are required to bring all original Certificates and testimonials along with one set of duly attested photocopy on the interview date. No TA/DA will be provided for attending the Interview.

• Candidates may please forward their Bio-data in advance to Dr. Kishanta Kumar Pradhan (Principal Investigator of the Project) through e-mail (kkpradhan@bitmesra.ac.in)

• Candidates appearing for online/offline interview should covey in advance to the PI.

• Selected candidate are expected to enroll for Ph.D. program of the institute after fulfilling admission criteria and would be given preference.

Terms & Conditions :
1. No TA/DA will be paid for attending the interview.
2. The above position is purely contractual.
3. Canvassing in any form will disqualify the candidate.

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward